Regarding the prognostic role of the MUC5B variant in HP patients, it has been shown that the variant is associated with poorer survival outcomes, a finding that contrasts with the survival advantage observed in IPF patients carrying the same variant [10]. Here, MUC5B is linked to idiopathic pulmonary fibrosis.